Versant Ventures is a healthcare‑focused venture capital firm investing in biotechnology and health‑tech companies developing novel therapeutics. Leveraging deep scientific and operating expertise through its discovery engines, the firm partners with academic founders to translate breakthroughs into commercial ventures. It provides hands‑on support and capital across multiple stages to build the next generation of life‑science companies.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
45.2%United Kingdom
16.1%Canada
9.7%Switzerland
3.2%Denmark
3.2%Other
3.2%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Versant Venture Capital VIII
Vintage 2021 • $560M
Versant Voyageurs II
Vintage 2021 • $140M
Versant Vantage II
Vintage 2021 • $250M